A new study by Tulane University researchers, published in the March edition of Molecular Endocrinology, provides insight into one of the ways diethylstilbesterol (DES) may alter the development of the uterus.
DES, a synthetic estrogen, was prescribed to prevent miscarriage in many women who were pregnant between 1941 until 1971. In 1971, DES was banned in the United States due to concerns about the occurrence of cancer and infertility in the daughters of women who took it.
“Several millions of pregnant women were treated with DES and we have continued to study and model the disease since it provides unique insights into what estrogenic chemicals may do to the developing fetus,” says study co-author John McLachlan, director of the Center for Bioenvironmental Research at Tulane and Xavier Universities. “There are other chemicals in our environment -- the results of industrial, agriculture and chemical processing -- that, while their estrogenic affect is weaker, may affect developing embryos in the same way. We need models to understand the cellular and genetic mechanisms by which environmental chemicals work. This study is a step in that direction.”
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences